NMR Characterization of the Metallo-β-lactamase from Bacteroides fragilis and Its Interaction with a Tight-Binding Inhibitor:  Role of an Active-Site Loop

SDB Scrofani, J Chung, JJA Huntley, SJ Benkovic… - Biochemistry, 1999 - ACS Publications
Understanding the structure and dynamics of the enzymes that mediate antibiotic resistance
of pathogenic bacteria will allow us to take steps to combat this increasingly serious public …

A metallo-β-lactamase enzyme in action: crystal structures of the monozinc carbapenemase CphA and its complex with biapenem

G Garau, C Bebrone, C Anne, M Galleni… - Journal of molecular …, 2005 - Elsevier
One strategy developed by bacteria to resist the action of β-lactam antibiotics is the
expression of metallo-β-lactamases. CphA from Aeromonas hydrophila is a member of a …

β-lactam antibiotics and β-lactamase enzymes inhibitors, part 2: our limited resources

S Alfei, AM Schito - Pharmaceuticals, 2022 - mdpi.com
β-lactam antibiotics (BLAs) are crucial molecules among antibacterial drugs, but the
increasing emergence of resistance to them, developed by bacteria producing β-lactamase …

Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria

K Bush, JF Fisher - Annual review of microbiology, 2011 - annualreviews.org
β-Lactamase evolution presents to the infectious disease community a major challenge in
the treatment of infections caused by multidrug-resistant gram-negative bacteria. Because …

The diversity, structure and regulation of β-lactamases

A Philippon, J Dusart, B Joris, JM Frere - Cellular and Molecular Life …, 1998 - Springer
β-Lactamase production is responsible for the appearance of a large number of pathogenic
bacterial strains exhibiting a high degree of resistance to β-lactam antibiotics. A large …

The identification of new metallo-β-lactamase inhibitor leads from fragment-based screening

P Vella, WM Hussein, EWW Leung, D Clayton… - Bioorganic & medicinal …, 2011 - Elsevier
The emergence of metallo-β-lactamases (MBLs) capable of hydrolysing a broad spectrum of
β-lactam antibiotics is particularly concerning for the future treatment of bacterial infections …